Plasma asymmetric dimethylarginine is associated with vulnerable plaque and long-term outcomes in stable coronary artery disease

Asymmetric dimethylarginine (ADMA) is considered to be an atherogenic molecule. We aimed to investigate the relationship between ADMA and plaque vulnerability assessed by optical coherence tomography (OCT) in patients with stable coronary artery disease (CAD). Two hundred and forty-five patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Shao-Sung, Huang, Wei-Chieh, Tsai, Chuan-Tsai, Chen, Ying-Ying, Lee, Sheng-Hua, Lu, Tse-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169809/
https://www.ncbi.nlm.nih.gov/pubmed/37160906
http://dx.doi.org/10.1038/s41598-023-32728-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169809/
https://www.ncbi.nlm.nih.gov/pubmed/37160906
http://dx.doi.org/10.1038/s41598-023-32728-9

Ejemplares similares